Acadia Pharmaceuticals
ACAD
ACAD
203 hedge funds and large institutions have $3.34B invested in Acadia Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 86 increasing their positions, 64 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
203
Holders Change
-16
Holders Change %
-7.31%
% of All Funds
5.07%
Holding in Top 10
2
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-66.67%
% of All Funds
0.05%
New
21
Increased
86
Reduced
64
Closed
35
Calls
$29.6M
Puts
$40.6M
Net Calls
-$11M
Net Calls Change
+$5.65M
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
$102M |
| 2 |
Goldman Sachs
New York
|
$53.2M |
| 3 |
Millennium Management
New York
|
$16.4M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
$39.1M |
| 5 |
State Street
Boston,
Massachusetts
|
$105M |
